The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127558241 12755824 1 I 20090401 20101105 20160916 20160916 EXP JP-SA-THYM-1002045 AVENTIS 61.00 YR A F Y 42.00000 KG 20160916 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127558241 12755824 1 PS THYMOGLOBULINE LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN 1 Intravenous (not otherwise specified) 157.5 MG/DAY, QD DOSE:157.5 MILLIGRAM(S)/24 HOURS 630 Y U C8034NA 103869 POWDER FOR SOLUTION FOR INFUSION QD
127558241 12755824 2 SS THYMOGLOBULINE LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN 1 Intravenous (not otherwise specified) 157.5 MG/DAY, QD DOSE:157.5 MILLIGRAM(S)/24 HOURS 630 Y U C8034NA 103869 POWDER FOR SOLUTION FOR INFUSION QD
127558241 12755824 3 C CICLOSPORIN CYCLOSPORINE 1 UNK 0
127558241 12755824 4 C PREDNISOLONE. PREDNISOLONE 1 UNK 0
127558241 12755824 5 C PRANLUKAST PRANLUKAST 1 UNK 0
127558241 12755824 6 C MAGNESIUM HYDROXIDE. MAGNESIUM HYDROXIDE 1 UNK 0
127558241 12755824 7 C AMLODIPINE BESILATE AMLODIPINE BESYLATE 1 UNK 0
127558241 12755824 8 C FILGRASTIM FILGRASTIM 1 UNK 0
127558241 12755824 9 C METHYLPREDNISOLONE SODIUM SUCCINATE. METHYLPREDNISOLONE SODIUM SUCCINATE 1 UNK 0
127558241 12755824 10 C RED BLOOD CELLS, CONCENTRATED HUMAN RED BLOOD CELL 1 Unknown UNK 0
127558241 12755824 11 C PLATELETS HUMAN PLATELET, ALLOGENIC 1 Unknown UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127558241 12755824 1 Aplastic anaemia
127558241 12755824 2 Aplastic anaemia
127558241 12755824 3 Aplastic anaemia
127558241 12755824 4 Premedication
127558241 12755824 5 Asthma
127558241 12755824 6 Prophylaxis against gastrointestinal ulcer
127558241 12755824 7 Hypertension
127558241 12755824 8 Infection prophylaxis
127558241 12755824 9 Premedication
127558241 12755824 10 Aplastic anaemia
127558241 12755824 11 Aplastic anaemia

Outcome of event

Event ID CASEID OUTC COD
127558241 12755824 HO
127558241 12755824 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127558241 12755824 Febrile neutropenia
127558241 12755824 Haemorrhagic diathesis
127558241 12755824 Thrombocytopenia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127558241 12755824 1 20090331 20090403 0
127558241 12755824 2 20090406 20090406 0
127558241 12755824 3 20090316 0
127558241 12755824 4 20090414 0
127558241 12755824 5 20090218 0
127558241 12755824 6 20090402 0
127558241 12755824 7 20090403 0
127558241 12755824 8 20090307 20090422 0
127558241 12755824 9 20090331 20090408 0
127558241 12755824 10 20090218 20100206 0
127558241 12755824 11 20090218 20100306 0